EUVIMEDEUVIMED entdecken
MetaanalyseVergleichsstudieSystematische ÜbersichtOpen Access · CC BY 4.0

Oral misoprostol ( PGE1 ) vs vaginal dinoprostone ( PGE2 ) for labor induction: individual participant data meta‐analysis of randomized controlled trials

S Y Tan iD, N Au, M D Peel, J M Dodd iD, A Deussen, P A Le Roux, D C Young, F Tessier, P Dallenbäch, D M R Croll, M Patabendige, K Palmer und 2 weitere

Ultrasound in Obstetrics & Gynecology · 2025

DOI: 10.1002/uog.70100 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Ultrasound in Obstetrics & Gynecology, 2025. Verfasst von S Y Tan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia. Hauptthemen laut MEDLINE: Misoprostol, Labor, Induced, Dinoprostone, Oxytocics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the effectiveness and safety of oral misoprostol vs vaginal dinoprostone for the induction of labor (IOL) using an individual participant data (IPD) meta‐analysis.

Methods

We used a Cochrane review and searched Ovid MEDLINE, Ovid Embase, Ovid Emcare, CINAHL Plus, Scopus and ClinicalTrials.gov to identify randomized controlled trials (RCTs) that compared oral misoprostol with vaginal dinoprostone for IOL in viable singleton pregnancies. We invited the authors of eligible trials to share their anonymized data. Primary outcomes were vaginal delivery, a composite measure of adverse maternal outcomes and a composite measure of adverse perinatal outcomes. IPD meta‐analysis was conducted using a two‐stage random‐effects model. An intention‐to‐treat approach was used for all analyses. Aggregate‐data meta‐analysis was undertaken with RCTs stratified by Trustworthiness in RAndomised Clinical Trials (TRACT) score.

Results

Of 18 eligible RCTs, eight provided IPD, of which five (1892 participants) met the TRACT criteria for trustworthiness. IPD meta‐analysis showed similar rates of vaginal delivery after IOL with oral misoprostol or vaginal dinoprostone (odds ratio (OR), 0.99 (95% CI, 0.80–1.22); I 2 = 0%). The rates of composite adverse perinatal outcome (adjusted odds ratio (aOR), 1.02 (95% CI, 0.61–1.72); I 2 = 0%) and composite adverse maternal outcome (aOR, 1.39 (95% CI, 0.72–2.69); I 2 = 0%) were also comparable between the groups. Of 10 RCTs that did not share IPD, seven met the TRACT criteria. Aggregate‐data meta‐analysis of the 12 RCTs (five with IPD and seven without IPD) meeting the trustworthiness criteria also showed comparable rates of vaginal delivery after oral misoprostol and after vaginal dinoprostone (OR, 1.08 (95% CI, 0.92–1.27)). In contrast, six studies not meeting the trustworthiness criteria (three with and three without IPD) reported a higher rate of vaginal delivery following oral misoprostol (OR, 1.34 (95% CI, 1.22–1.48)), resulting in an inflated overall estimate of the vaginal delivery rate after oral misoprostol based on all data (OR, 1.19 (95% CI, 1.05–1.36)).

Conclusion

IOL with oral misoprostol or vaginal dinoprostone results in comparable rates of vaginal delivery and composite perinatal and maternal adverse outcomes. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MisoprostolLabor, InducedDinoprostoneOxytocicsHumansPregnancyFemaleAdministration, IntravaginalRandomized Controlled Trials as TopicAdministration, OralPregnancy Outcome

Stichwörter der Autor:innen

PGE1PGE2dinoprostoneindividual participant datainduction of labormisoprostolsafetysystematic reviewvaginal delivery

Substanzen

MisoprostolDinoprostoneOxytocics

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia.
  • Department of Obstetrics and Gynaecology, Monash Health, Clayton, VIC, Australia.
  • Department of Obstetrics and Gynaecology and Robinson Research Institute, University of Adelaide, Women's and Children's Hospital, North Adelaide, SA, Australia.
  • Women's and Babies Division, Women's and Children's Hospital, North Adelaide, SA, Australia.
  • Department of Obstetrics and Gynaecology, University of Cape Town, Cape Town, South Africa.
  • Department of Obstetrics and Gynaecology, Dalhousie University, IWK Health Centre, Halifax, NS, Canada.

ORCID-Profile: S Y Tan, J M Dodd, W Li, B W Mol

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Tan, S. Y., Au, N., Peel, M. D., Dodd, J. M., Deussen, A., Le Roux, P. A., Young, D. C., Tessier, F., Dallenbäch, P., Croll, D. M. R., Patabendige, M., Palmer, K., Li, W., & Mol, B. W. (2025). Oral misoprostol ( PGE1 ) vs vaginal dinoprostone ( PGE2 ) for labor induction: individual participant data meta‐analysis of randomized controlled trials. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.70100

Vancouver

Tan SY, Au N, Peel MD, Dodd JM, Deussen A, Le Roux PA, et al. Oral misoprostol ( PGE1 ) vs vaginal dinoprostone ( PGE2 ) for labor induction: individual participant data meta‐analysis of randomized controlled trials. Ultrasound in Obstetrics & Gynecology. 2025. doi:10.1002/uog.70100

BibTeX
@article{Tan2025,
  author = {Tan, S Y and Au, N and Peel, M D and Dodd, J M and Deussen, A and Le Roux, P A and Young, D C and Tessier, F and Dallenbäch, P and Croll, D M R and Patabendige, M and Palmer, K and Li, W and Mol, B W},
  title = {Oral misoprostol ( PGE1 ) vs vaginal dinoprostone ( PGE2 ) for labor induction: individual participant data meta‐analysis of randomized controlled trials},
  journal = {Ultrasound in Obstetrics & Gynecology},
  year = {2025},
  doi = {10.1002/uog.70100}
}
Kostenlos starten →